An HCP survey-based active surveillance study to assess the safety of fixed dose combination of Levonorgestrel-Ethinyloestradiol (brand name Ovral-L) in the management of primary dysmenorrhea, endometriosis, and abnormal uterine bleeding among Indian females - Protocol# B6261001